RecruitingNCT07016035

Translation and Validation of the French mPCOSQ (mPCOSQ-F).

Translation and Validation of the French Version of the Health-related Quality of Life Questionnaire for the Polycystic Ovary Syndrome: the mPCOSQ-F.

Sponsor

CHU de Reims

Enrollment

350 participants

Start Date

May 12, 2025

Study Type

OBSERVATIONAL

Conditions

Polycystic Ovary Syndrome Health-related Quality of Life

Summary

This study is a prospective, observational, bicentric study, evaluating the validity and reliability of a French version of the mPCOSQ questionnaire (mPCOSQ-F), used to assess health-related quality of life (HRQOL) in women with polycystic ovary syndrome. The first stage of the study consisted in translating the questionnaire from English to French. Patients agreeing to take part in the study will complete the mPCOSQ-F and the SF-36 (generic HRQOL questionnaire). After 1 to 2 weeks, patients will receive the mPCOSQ-F and complete it again.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Inclusion Criteria5

Women aged 18 to 45
Fluent in french
Having a diagnosis of PCOS according to the international recommendations published in 2023
Willing to participate in the study
Affiliated to the french social security system

Exclusion Criteria3

Diagnosis of adrenal hyperplasia, androgen-producing tumor, Cushing's syndrome, or thyroid disorder
Pregnancy or breast-feeding
Under legal protection

Interventions

OTHERmPCOSQ-F and SF-36

Questionnaires

Locations(1)

Damien JOLLY

Reims, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07016035